Komori
Vega corporation (3542) · FactRestated

Quarterly Research and Development Expense Disclosure

First written in FY2017-Q1. 26 of 28 entries say "Restated". Latest entry: FY2025-H1.

28entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2021RestatedFY2022-Q2 – FY2025-H12016: 220162017: 420172018: 420182019: 220192020: 420202021: 420212022: 320222023: 320232024: 22024
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 191 companies write about · 0 as a headwind · 180 as a tailwind

97 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 191 companies compared. The sentences above are computed from all 191.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1RestatedAnnual report

    「R&D expenditure for the interim accounting period was ¥36 million. There was no material change in the status of the company's R&D activities during the interim accounting period.」

    The company disclosed R&D expenditure of ¥36 million for the interim accounting period and stated that there had been no material change in its R&D activities.
  2. FY2024-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥18 million. There was no material change in the status of the company's R&D activities during the cumulative third quarter.」

    The company disclosed R&D expenditure of ¥18 million for the cumulative third quarter and stated that there had been no material change in its R&D activities.
  3. FY2024-Q2RestatedAnnual report

    「R&D expenditure for the cumulative second quarter was ¥11 million. There was no material change in the status of the company's R&D activities during the cumulative second quarter.」

    The company continued its R&D activities and disclosed R&D expenditure of ¥11 million for the cumulative second quarter.
  4. FY2024-Q1RestatedAnnual report

    「The company conducts R&D on services using advanced technologies such as VR (virtual reality) and AR (augmented reality) in order to continue creating high-value-added services that further improve customer satisfaction. Total R&D expenditure for the cumulative first quarter was ¥4 million.」

    The company continued R&D on services using advanced technologies such as VR and AR and disclosed R&D expenditure of ¥4 million for the first quarter.
  5. FY2023-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥22 million. There was no material change in the status of the company's R&D activities during the cumulative third quarter.」

    The company continued its R&D activities and disclosed R&D expenditure of ¥22 million for the cumulative third quarter.
  6. FY2023-Q1RestatedAnnual report

    「The company conducts R&D on services using advanced technologies such as VR (virtual reality) and AR (augmented reality) in order to continue creating high-value-added services that further improve customer satisfaction. Total R&D expenditure for the cumulative first quarter was ¥8 million.」

    The company continued R&D on services using advanced technologies such as VR and AR and disclosed R&D expenditure of ¥8 million for the first quarter.
  7. FY2022RestatedAnnual report

    「Total R&D expenditure for the fiscal year was ¥34 million. The cross-border e-commerce platform DOKODEMO, which had been classified as an R&D activity through the previous fiscal year, has moved from the R&D phase to the business expansion phase and is therefore excluded from the scope of R&D activities.」

    The company disclosed R&D expenditure of ¥34 million, and DOKODEMO continued to be classified as having moved from the R&D phase to the business expansion phase.
  8. FY2022-Q3RestatedAnnual report

    「Total R&D expenditure for the cumulative third quarter was ¥23 million. The cross-border e-commerce platform DOKODEMO, which had been classified as an R&D activity through the previous fiscal year, has moved from the R&D phase to the business expansion phase and is therefore excluded from the scope of R&D activities.」

    R&D expenditure was ¥23 million, and DOKODEMO continued to be classified as having moved from the R&D phase to the business expansion phase.
  9. FY2022-Q2RestatedAnnual report

    「Total R&D expenditure for the cumulative second quarter was ¥15 million. The cross-border e-commerce platform DOKODEMO, which had been classified as an R&D activity through the previous fiscal year, has moved from the R&D phase to the business expansion phase and is therefore excluded from the scope of R&D activities.」

    The company recorded R&D expenditure of ¥15 million. As DOKODEMO had moved from the R&D phase to the business expansion phase, it continued to be excluded from the scope of R&D activities.
  10. FY2022-Q1ReframedAnnual report

    「Total R&D expenditure for the cumulative first quarter was ¥6 million. The cross-border e-commerce platform DOKODEMO, which had been classified as an R&D activity through the previous fiscal year, has moved from the R&D phase to the business expansion phase and is therefore excluded from the scope of R&D activities.」

    R&D expenditure was ¥6 million. DOKODEMO was excluded from the scope of R&D activities, with its classification changed from the R&D phase to the business expansion phase.
  11. FY2021RestatedAnnual report

    「Total R&D expenditure for the fiscal year was ¥438 million.」

    The company disclosed ¥438 million in R&D expenditure for enhancing DOKODEMO's functionality and expanding its services. This was an increase from ¥308 million in the previous fiscal year.
  12. FY2021-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥305 million. There was no material change in the status of the company's R&D activities during the cumulative third quarter.」

    The company disclosed R&D expenditure of ¥305 million for the cumulative third quarter and stated that there had been no material change in its R&D activities.
  13. FY2021-Q2RestatedAnnual report

    「R&D expenditure for the cumulative second quarter was ¥169 million. There was no material change in the status of the company's R&D activities during the cumulative second quarter.」

    The company disclosed R&D expenditure of ¥169 million for the cumulative second quarter and stated that there had been no material change in its R&D activities.
  14. FY2021-Q1RestatedAnnual report

    「R&D expenditure for the cumulative first quarter was ¥67 million. There was no material change in the status of the company's R&D activities during the cumulative first quarter.」

    The company disclosed R&D expenditure of ¥67 million for the first quarter and stated that there had been no material change in its R&D activities.
  15. FY2020RestatedAnnual report

    「Total R&D expenditure for the fiscal year was ¥308 million.」

    The company disclosed full-year R&D expenditure of ¥308 million for activities aimed at enhancing DOKODEMO's functionality and expanding its services.
  16. FY2020-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥245 million. There was no material change in the status of the company's R&D activities during the cumulative third quarter.」

    The company disclosed R&D expenditure of ¥245 million for the cumulative third quarter and stated that there had been no material change in its R&D activities.
  17. FY2020-Q1RestatedAnnual report

    「R&D expenditure for the cumulative first quarter was ¥96 million. There was no material change in the status of the company's R&D activities during the cumulative first quarter.」

    The company disclosed R&D expenditure of ¥96 million for the first quarter and stated that there had been no material change in its R&D activities.
  18. FY2019-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥337 million. There was no material change in the status of the company's R&D activities during the cumulative third quarter.」

    The company disclosed R&D expenditure of ¥337 million for the cumulative third quarter and stated that there had been no material change in its R&D activities.
  19. FY2019-Q2RestatedAnnual report

    「R&D expenditure for the cumulative second quarter was ¥219 million. There was no material change in the status of the company's R&D activities during the cumulative second quarter.」

    The company disclosed R&D expenditure of ¥219 million for the cumulative second quarter and stated that there had been no material change in its R&D activities.
  20. FY2019-Q1RestatedAnnual report

    「R&D expenditure for the cumulative first quarter was ¥108 million. There was no material change in the status of the company's R&D activities during the cumulative first quarter.」

    The company disclosed R&D expenditure of ¥108 million for the first quarter and stated that there had been no material change in its R&D activities.
  21. FY2018RestatedAnnual report

    「Total R&D expenditure for the fiscal year was ¥439 million.」

    The company disclosed annual R&D expenditure of ¥439 million for enhancing the functionality of DOKODEMO and building a furniture- and interior-focused e-commerce platform.
  22. FY2018-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥318 million. There was no material change in the status of the company's R&D activities during the cumulative third quarter.」

    The company disclosed R&D expenditure of ¥318 million for the cumulative third quarter and stated that there had been no material change in its R&D activities.
  23. FY2018-Q2RestatedAnnual report

    「R&D expenditure for the cumulative second quarter was ¥211 million. There was no material change in the status of the company's R&D activities during the cumulative second quarter.」

    The company disclosed R&D expenditure of ¥211 million for the cumulative second quarter and stated that there had been no material change in its R&D activities.
  24. FY2018-Q1RestatedAnnual report

    「R&D expenditure for the cumulative first quarter was ¥100 million. There was no material change in the status of the company's R&D activities during the cumulative first quarter.」

    The company disclosed R&D expenditure of ¥100 million for the first quarter and stated that there had been no material change in its R&D activities.
  25. FY2017RestatedAnnual report

    「Total R&D expenditure for the fiscal year was ¥263 million.」

    The company disclosed full-year R&D expenditure of ¥263 million, primarily for enhancing the functionality of its cross-border e-commerce site.
  26. FY2017-Q3RestatedAnnual report

    「R&D expenditure for the cumulative third quarter was ¥187 million.」

    The company disclosed R&D expenditure of ¥187 million for the cumulative third quarter and stated that there had been no material change in its R&D activities.
  27. FY2017-Q2RestatedAnnual report

    「R&D expenditure for the cumulative second quarter was ¥120 million.」

    The company disclosed R&D expenditure of ¥120 million for the cumulative second quarter and stated that there had been no material change in its R&D activities.
  28. FY2017-Q1First statedAnnual report

    「R&D expenditure for the cumulative first quarter was ¥53 million.」

    The company disclosed R&D expenditure of ¥53 million for the cumulative first quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Vega corporation's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Quarterly Research and Development Expense Disclosure | Vega corporation Co.,Ltd. (3542) | Komori